Brian Lundstrom

Title: Brian Lundstrom: Innovator in Epilepsy Treatment Technologies

Introduction

Brian Lundstrom is a notable inventor based in Redmond, WA (US). He has made significant contributions to the field of medical technology, particularly in the treatment of epilepsy. His innovative approach focuses on utilizing quantified biomarkers to enhance therapy systems.

Latest Patents

Lundstrom holds a patent for "Therapy systems with quantified biomarker targeting, including for epilepsy treatment, and associated systems and methods." This patent describes a computer-based method for establishing epilepsy treatment parameters for patients. The method involves receiving multiple indications of interictal EEG biomarkers over a period of time and processing these indications to produce a processed biomarker. This processed biomarker is then used to identify target locations in the patient's brain for delivering electrical therapy signals aimed at reducing or eliminating epileptic activity.

Career Highlights

Throughout his career, Brian Lundstrom has worked with prominent organizations such as Cadence Neuroscience, Inc. and the Mayo Foundation for Medical Education and Research. His work in these institutions has allowed him to develop and refine his innovative approaches to epilepsy treatment.

Collaborations

Lundstrom has collaborated with notable professionals in his field, including Kent Leyde and Gregory A. Worrell. These collaborations have contributed to the advancement of his research and the development of effective treatment methodologies.

Conclusion

Brian Lundstrom's work in the field of epilepsy treatment through quantified biomarker targeting represents a significant advancement in medical technology. His innovative patent and career achievements highlight his dedication to improving patient outcomes.